{"database": "openregs", "table": "dockets", "rows": [["FDA-2026-N-10396", "FDA", "Amneal Pharmaceuticals of New York, LLC; Withdrawal of Approval of Abbreviated New Drug Application for Celecoxib Capsules, 50 Milligrams, 100 Milligrams, 200 Milligrams, and 400 Milligrams", "Nonrulemaking", "2026-10-09T14:15:50Z", "0b000064b94cb9ba", null, null, null, null, null, null, null, null, null, null, "list_pull"]], "columns": ["id", "agency_id", "title", "docket_type", "last_modified", "object_id", "rin", "dkabstract", "category", "subtype", "keywords", "program", "short_title", "effective_date", "organization", "attrs_raw", "attr_source"], "primary_keys": ["id"], "primary_key_values": ["FDA-2026-N-10396"], "units": {}, "query_ms": 0.23310910910367966, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}